• The University of Western Australia (M509), 35 Stirling Highway,

    6009 Perth

    Australia

  • 427 Citations
  • 11 h-Index
20102019
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Albert Farrugia ia an internationally recognised medical scientisit in the field of biotherapeutics. He has been active in this area for fourty years, over the course of which he has engaged in research, regulatory and clinical aspects in several countries. He has contributed widely to the peer-reviewed medical and scientific literature, with over 170 publivcations including 130 papers listed in PubMed. His interests include the development of strategic direcctions for the generation and clinical implementation of novel therapies, the use of health technology assessment in assisting health policy and the furhterance of advocacy for patients with rare diseases. He holds a Bachelor's degree from the Univisrsity of Malta and a PhD from the University of Edinburgh. In 2009 he was awarded the Ruth Sanger Oration Medal for services to blood transfusion in the Australian and Asi Pacific regions.

Fingerprint Dive into the research topics where Albert Farrugia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Hemophilia A Medicine & Life Sciences
Blood Coagulation Factors Medicine & Life Sciences
Immunoglobulins Medicine & Life Sciences
Safety Medicine & Life Sciences
Albumins Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

Comparing objective and self-reported measures of adherence in haemophilia

Guedes, V. G., Corrente, J. E., Farrugia, A., Thomas, S., Wachholz, P. A. & de Oliveira Vidal, E. I., 19 Jul 2019, In : Haemophilia.

Research output: Contribution to journalArticle

Blood Coagulation Factors
Hemophilia A
Self Report
Social Desirability
Patient Compliance
1 Citation (Scopus)

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study

Pulvirenti, F., Cinetto, F., Pecoraro, A., Carrabba, M., Crescenzi, L., Bonanni, L., Fabio, G., Neri, R., Agostini, C., Spadaro, G., Tabolli, S., Farrugia, A., Quinti, I. & Milito, C., Feb 2019, In : Journal of Clinical Immunology. 39, 2, p. 159-170 12 p.

Research output: Contribution to journalArticle

Open Access
Passive Immunization
Multicenter Studies
Immunoglobulins
Appointments and Schedules
Quality of Life

Impact of the route of immunoglobulin administration on health-related quality of life in patients with CVID: A prospective multicenter study

Pulvirenti, F., Cinetto, F., Pecoraro, A., Carrabba, M., Crescenzi, L., Neri, R., Fabio, G., Agostini, C., Spadaro, G., Farrugia, A., Quinti, I. & Milito, C., Aug 2019, In : Allergy. 74, p. 44-44 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients

Castaman, G., Borchiellini, A., Santagostino, E., Tagariello, G., Serban, M., Uscatescu, M., Truica, C., Albert, F. & Morfini, M., 11 Sep 2019, In : Haemophilia.

Research output: Contribution to journalLetter

Prizes

Ruth Sanger Oration Medal

Albert Farrugia (Recipient), 2009

Prize: Award

blood transfusion